SUBSCRIBE
SUBSCRIBE
News   Deals

Targacept, Inc. Sets IPO At 5 Million Shares, $11-$13/Share

March 16, 2006 | 
1 min read
WASHINGTON, March 16 (Reuters) - Biopharmaceutical company Targacept Inc. on Thursday set its planned initial public offering at 5 million shares for between $11 and $13 per share.
IPO
MORE ON THIS TOPIC
External view of Novartis' office in Massachusetts
Collaboration
Novartis Sticks With Monte Rosa in Second Molecular Glue Deal Worth up to $5.7B
September 15, 2025
 · 
2 min read
 · 
Tristan Manalac
Glowing red up arrow surrounded by dollar signs in black background. Illustration of the concept of positive return on investment and business earnings
IPO
UPDATE: Neuroscience Biotech LB Pulls Off Upsized $285M IPO
September 11, 2025
 · 
2 min read
 · 
Annalee Armstrong
Rough road to money stock illustration
Mergers & Acquisitions
Hectic Markets, Emotions Lead Biotechs To Tack On CVRs
September 10, 2025
 · 
6 min read
 · 
Annalee Armstrong
Money coins flow from tap. Cash flow with tiny businessmen open the tap symbol illustration
Mergers & Acquisitions
Novartis’ Busy BD Team Keeps 2025 Bolt-On Deal Promises
September 9, 2025
 · 
2 min read
 · 
Annalee Armstrong